Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-002942
Filing Date
2023-02-21
Accepted
2023-02-21 18:10:02
Documents
1
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 form4-02212023_110227.html 4  
1 form4-02212023_110227.xml 4 12654
  Complete submission text file 0001415889-23-002942.txt   13950
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Reents Scott T (Reporting) CIK: 0001937048 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 23649857